Form 4: Boston Scientific Executive Arthur C. Butcher Reports Stock Transactions
SEC Form 4 Filing
Arthur C. Butcher, EVP & Group President at Boston Scientific, reports acquisition and disposal of common stock and derivative securities.
Summary
- Arthur C. Butcher, an executive at Boston Scientific, filed a Form 4 detailing changes in beneficial ownership.
- The transactions involve common stock and derivative securities, including restricted stock units and stock options.
- Butcher acquired shares through the vesting of restricted stock units and stock options.
- He also disposed of shares to cover tax obligations.
- Following these transactions, Butcher directly owns 22,235 shares of common stock and indirectly owns 13,364 shares through a 401(k) plan.
- He also holds 8,950 restricted stock units and 23,031 stock options.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing stock transactions by an executive, and does not inherently convey positive or negative sentiment.
Future Outlook
The reporting person will receive shares of common stock in future years as the restricted stock units vest in installments.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the trading activities of company insiders. These filings are closely watched by investors as they can provide insights into management's view of the company's prospects.
Comparison to Industry Standards
- Executive compensation packages often include stock options and restricted stock units to align management's interests with those of shareholders.
- The vesting schedules for these equity grants are typically spread over several years to incentivize long-term performance.
- Similar filings are made by executives at comparable medical device companies such as Medtronic (MDT) and Abbott Laboratories (ABT).
Stakeholder Impact
- The transactions reported in the Form 4 filing may be of interest to shareholders as they provide insight into the executive's holdings and trading activity.
- The vesting of restricted stock units and stock options can impact the company's share dilution.
Key Dates
| Date | Description |
|---|---|
| 02/13/2025 | Date of earliest transaction and grant of restricted stock units and stock options. |
| 02/14/2025 | Transaction date for acquisition and disposal of common stock. |
| 02/16/2025 | Transaction date for acquisition and disposal of common stock. |
| 02/17/2025 | Transaction date for acquisition and disposal of common stock. |
| 02/18/2025 | Date of signature for the Form 4 filing. |
| 02/13/2026 | First anniversary of grant date for new RSUs and stock options, when vesting begins. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.